Melanoma
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Equine melanoma is a tumour of pigment-producing melanocytes. It is especially common in ageing grey horses, in which inherited greying biology predisposes melanocytes to proliferate. Nodules typically begin beneath the tail, around the anus and perineum, on the sheath, lips or parotid region. They may be solitary, multiple or merge into large lobulated masses.
Many grey-horse melanomas grow slowly for years, but “benign” appearance is not a guarantee of harmless behaviour. Tumours can ulcerate, become infected, obstruct defaecation or urination, interfere with tack and compress nerves or airways. Internal masses may involve lymph nodes, guttural pouches, salivary glands or organs. A rapid growth phase or distant spread can develop after prolonged stability.
Melanocytic tumours in non-grey horses and congenital lesions have different biological behaviour and deserve biopsy rather than assumption. Black colour alone does not diagnose melanoma; sarcoids, squamous cell carcinoma and other pigmented masses can resemble it. In grey horses, lymph-node pigment may represent tumour or accumulated pigment-laden cells, so clinical significance requires context.
Not every small tumour needs immediate removal, but all require mapping and follow-up. Early treatment is technically easier before numerous perineal nodules coalesce. Prognosis is excellent for a completely removed solitary benign lesion and more guarded for extensive, internal or rapidly progressive disease. New tumours can arise elsewhere even after successful local treatment because the horse’s predisposition remains.
Grey horses commonly develop melanocytic tumours under the tail, around the anus, lips and parotid region as they age. Many remain slow growing for years, but others enlarge, ulcerate or spread internally. A dark skin mass in a non-grey horse has a different risk profile, and absence of external obstruction does not exclude deeper parotid or guttural-pouch involvement.
Screening & Early Detection
A complete skin and mucosal examination includes lifting the tail, inspecting anus and perineum, sheath or udder, lips, eyelids and parotid areas. Each mass is measured and photographed on a body map. Rectal examination, endoscopy or ultrasound may be needed when defaecation, swallowing or upper-airway function is affected.
Fine-needle aspiration or biopsy confirms melanocytic origin and evaluates malignancy, particularly in a non-grey horse, unusual site or rapidly changing mass. Sampling is planned so haemorrhage and future excision can be managed. Ultrasound defines depth; CT, MRI or scintigraphy may investigate head, guttural-pouch or internal disease. Routine blood tests do not screen effectively for melanoma.
Owners should reassess size, ulceration, discharge and interference at least several times yearly. Difficulty passing manure or urine, bleeding, facial nerve change, respiratory noise or sudden enlargement prompts immediate evaluation. A pre-purchase examination records existing lesions but cannot predict exact growth rate. There is no reliable blood marker that rules out internal spread.
Rectal examination and ultrasound assess internal masses when tail-head disease is extensive or manure passage changes.
Treatment & Management
Small accessible tumours can be removed surgically or by laser, ideally before they merge with adjacent lesions. Cryotherapy can assist selected superficial masses. Large lesions may be debulked to restore function even when complete margins are impossible. Perineal surgery requires planning for contamination, wound contraction and preservation of anal or urinary function.
Local chemotherapy or electrochemotherapy with agents such as cisplatin can improve control for incompletely resectable disease. Systemic treatment options remain limited and evidence for cimetidine is poor. Immunotherapies and melanoma vaccines are used experimentally or off-label in specialist settings; owners should receive realistic information about response and cost.
Stable small nodules in low-risk locations may be monitored rather than repeatedly traumatised. Ulcerated masses receive fly control, hygiene, pain relief and treatment of secondary infection while definitive options are considered. Internal obstruction or extensive invasive disease may make euthanasia the humane choice. After any treatment, the whole horse—not just the operated site—is checked regularly because additional tumours commonly develop. Early intervention is generally more successful than waiting for a mass to compromise essential function.
Manure passage and swallowing are supported promptly when a mass causes mechanical obstruction.
Breeds or species affected
Arabian
Open horse breed description, care requirements and conditions
Shagya Arabian
Open horse breed description, care requirements and conditions
Thoroughbred
Open horse breed description, care requirements and conditions
Andalusian
Open horse breed description, care requirements and conditions
Lusitano
Open horse breed description, care requirements and conditions
Lipizzaner
Open horse breed description, care requirements and conditions
Irish Sport Horse
Open horse breed description, care requirements and conditions
Camargue
Open horse breed description, care requirements and conditions
Percheron
Open horse breed description, care requirements and conditions
Boulonnais
Open horse breed description, care requirements and conditions
Welsh Pony and Cob
Open horse breed description, care requirements and conditions
Connemara Pony
Open horse breed description, care requirements and conditions